Helius Medical Technologies (TSE:HSM) Stock Price Down 4.3%

Shares of Helius Medical Technologies Inc (TSE:HSM) were down 4.3% during trading on Thursday . The stock traded as low as C$1.85 and last traded at C$2.02, approximately 10,300 shares changed hands during mid-day trading. A decline of 48% from the average daily volume of 19,806 shares. The stock had previously closed at C$2.11.

The company has a market cap of $55.44 million and a PE ratio of -5.87. The company’s 50 day moving average is C$2.29 and its 200 day moving average is C$3.04. The company has a current ratio of 3.40, a quick ratio of 3.15 and a debt-to-equity ratio of 5.56.

Helius Medical Technologies (TSE:HSM) last posted its quarterly earnings results on Thursday, August 8th. The company reported C($0.29) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of C($0.34) by C$0.05. The company had revenue of C$0.69 million during the quarter, compared to analysts’ expectations of C$0.54 million. Analysts expect that Helius Medical Technologies Inc will post 0.12 EPS for the current year.

Helius Medical Technologies Company Profile (TSE:HSM)

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, or acquiring noninvasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a medical device in Canada for the treatment of chronic balance deficit associated with a mild to moderate traumatic brain injury.

Read More: What does relative strength index mean?

Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.